Systems for Identifying New Drugs Are Often Faulty

Abstract excerpt

Screening potential anticancer agents to find ones promising enough to make human clinical trials worthwhile has not been as straightforward as researchers would like. Not only have very few of the drugs that showed anticancer activity in animals carrying transplanted human tumors--known as xenografts--made it into the clinic, but a recent study conducted at the National Cancer Institute suggests that the tests...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genetics, Bioinformatics, and Biomedical Research
• Share to Science, Research, and Medicine